Oncopeptides ranked among the top 10 companies in the Nordic Business Diversity Index 2024

February 9, 2024

Oncopeptides was recently ranked in the top 10 in the Nordic Business Diversity Index’s Sweden small-cap category. The Nordic Business Diversity Index is a study annually conducted by the sustainability consultancy Impaktly and assesses the diversity of senior leadership in over 600 Nordic listed companies based on the variables gender, age, nationality and education. This year, Oncopeptides ranked as number 9 in the Sweden small-cap category.

At Oncopeptides, we believe that diversity, inclusivity, and equality are key factors that determine the success of our business. While this recognition is a testament to our work within some important aspects of diversity, we are also dedicated to keep improving and working with our employees/organization to make sure that we build a culture that welcomes diversity on all levels.

You can read more about Oncopeptides approach to social sustainability and responsibility here.